Chinese PD-LRRK2 Registry

The purpose of the Chinese PD-LRRK2 Registry(CPD-LRRK2R) is to develop a database of patients of Parkinson's disease with leucine-rich repeat kinase 2 (LRRK2) gene variants in mainland China.

Study identifier: NCT03523104. Status: RECRUITING.

Study records are sourced from ClinicalTrials.gov. Confirm current eligibility, recruiting status, and locations in the official record.

View the official ClinicalTrials.gov record for NCT03523104

Browse Parkinson's clinical trials